Bradley B J, Haskins K, La Rosa F G, Lafferty K J
Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver 80262.
Diabetes. 1992 Dec;41(12):1603-8. doi: 10.2337/diab.41.12.1603.
A panel of CD4+ T-cell clones has been isolated from the spleen and lymph nodes of diabetic NOD mice. These clones have been shown to be islet-specific both in vivo and in vitro. One of the clones, BDC-6.9, initiates extensive damage to islet tissue when placed adjacent to an NOD islet graft that has been used to reverse diabetes in (CBA x NOD)F1 recipients or when injected intraperitoneally into such animals. In this study, we show that BDC-6.9 T cells can initiate islet destruction in the absence of detectable CD8 T cells either in the periphery or in the lesion that develops after the transfer of the cloned islet-reactive T cells.
已从糖尿病NOD小鼠的脾脏和淋巴结中分离出一组CD4 + T细胞克隆。这些克隆在体内和体外均显示出对胰岛具有特异性。其中一个克隆BDC-6.9,当置于已用于逆转(CBA×NOD)F1受体糖尿病的NOD胰岛移植物附近时,或腹腔注射到此类动物体内时,会对胰岛组织造成广泛损伤。在本研究中,我们表明,在克隆的胰岛反应性T细胞转移后,无论是在外周血还是在病变中,BDC-6.9 T细胞在没有可检测到的CD8 T细胞的情况下也能引发胰岛破坏。